Quality of life assessment in clinical cancer research
1994; Springer Nature; Volume: 70; Issue: 1 Linguagem: Inglês
10.1038/bjc.1994.240
ISSN1532-1827
AutoresManfred Olschewski, Gabi Schulgen, Martin Schumacher, DG Altman,
Tópico(s)Childhood Cancer Survivors' Quality of Life
ResumoClassical end-points in clinical therapeutic trials in oncology are usually defined by total, recurrence-free or systemic disease-free survival.Primarily, these allow an adequate de- scription of the biological course of the disease.In current
Referência(s)